Kochen W, Byrd D J, Bühner R, Bühlen E
Z Klin Chem Klin Biochem. 1975 Jan;13(1):1-12.
The products of the oxidative degradation of tryptophan via the kynurenine pathway were quantitatively determined in the urine of ten untreated patients with phenylketonuria, aged 4--35 years. All the patients were sevrely mentally retarded. The results of the analysis suggest a division of the patients into two groups, A and B. The patients of group A showed a basal urinary excretion of kynurenine, kynurenic acid, 3-hydroxykynurenine and xanthurenic acid which lies in the lower part of the normal range. The increase in excretion of tryptophan metabolites under tryptophan loading was, however, significantly less than in controls. On the average, only 0.63 % of the load was excreted in the form of these assayed metabolites; in contrast, the control value is 1,13 %. In group B, the rate of excretion was higher than normal under basal and loading conditions. The post-tryptophan excretion was four times greater than that of controls (4.64 %). 3-hydroxyanthranilic acid could only be detected in group B after loading. The metabolite 8-hydroxyquinaldic acid, which is supposed to be an abnormal metabolic product of tryptophan, was excreted in milligram amounts. The analysis of the metabolites of 3-hydroxyanthranilic acid showed that the excretion of N1-methylnicotinamide and N1-methyl-2-pyridone-5-carboxamide was within the normal range. The excretion of nicotinic acid and its amide was sporadic in both the patients and controls. Other theoretically possible metabolites in the pathway could not be found. A number of unidentified metabolites could be detected by thin-layer chromatography in the basal state. The excretion of these metabolites was greatly augmented after tryptophan loading. Other substances which were not detectable in the basal state became evident on loading. A number of these metabolites are characteristic either of group A or B. The structural identification of one of the new products has been hindered by its instability. A stable cleavage product was identified as omicron-aminoacetophenon by mass-spectroscopy. This metabolite its typical for group B. The possible influence of the blood phenylalanine on the metabolism of tryptophan in phenylketonuria is discussed.
通过犬尿氨酸途径对色氨酸进行氧化降解的产物,在10名未经治疗的苯丙酮尿症患者(年龄4至35岁)的尿液中进行了定量测定。所有患者均有严重智力发育迟缓。分析结果表明患者可分为A、B两组。A组患者尿中犬尿氨酸、犬尿酸、3 - 羟基犬尿氨酸和黄尿酸的基础排泄量处于正常范围下限。然而,色氨酸负荷后色氨酸代谢产物的排泄增加量明显低于对照组。平均而言,这些被测代谢产物仅以0.63%的负荷量排出;相比之下,对照值为1.13%。在B组中,基础和负荷条件下的排泄率均高于正常水平。色氨酸负荷后的排泄量比对照组高四倍(4.64%)。仅在B组负荷后检测到3 - 羟基邻氨基苯甲酸。代谢产物8 - 羟基喹哪啶酸被认为是色氨酸的异常代谢产物,以毫克量排出。对3 - 羟基邻氨基苯甲酸代谢产物的分析表明,N1 - 甲基烟酰胺和N1 - 甲基 - 2 - 吡啶酮 - 5 - 羧酰胺的排泄量在正常范围内。烟酸及其酰胺在患者和对照组中的排泄均为散发性。该途径中其他理论上可能的代谢产物未被发现。通过薄层色谱法在基础状态下可检测到一些未鉴定的代谢产物。色氨酸负荷后这些代谢产物的排泄量大幅增加。其他在基础状态下不可检测的物质在负荷后变得明显。其中一些代谢产物是A组或B组所特有的。一种新产品的结构鉴定因其不稳定性而受阻。通过质谱法鉴定出一种稳定的裂解产物为邻氨基苯乙酮。这种代谢产物是B组所特有的。文中讨论了血液中苯丙氨酸对苯丙酮尿症患者色氨酸代谢的可能影响。